Aimbiotech
1 known investors
AIM Biotech develops humanized 3D microfluidic organ-on-a-chip platforms (idenTx and organiX) and provides contract research services for drug discovery, immuno-oncology, and functional precision medicine. Its products and assays let pharmaceutical and academic researchers culture organoids, biopsies, and tissues in vivo-like conditions as an alternative to animal models.
Investors · 1
Competitors · 2
by search overlap
Seeking Alpha9 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Iambic9 shared keywordsIambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors. It serves the pharmaceutical industry through both its own drug pipeline and partnerships.
Companies competing with Aimbiotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Aimbiotech do?
- AIM Biotech develops humanized 3D microfluidic organ-on-a-chip platforms (idenTx and organiX) and provides contract research services for drug discovery, immuno-oncology, and functional precision medicine. Its products and assays let pharmaceutical and academic researchers culture organoids, biopsies, and tissues in vivo-like conditions as an alternative to animal models.
- Who are Aimbiotech's investors?
- Aimbiotech's investors include Elev8.vc.